Home/Pipeline/FerroTrace®

FerroTrace®

Upper gastrointestinal cancers (gastric, esophageal)

Phase 1Active

Key Facts

Indication
Upper gastrointestinal cancers (gastric, esophageal)
Phase
Phase 1
Status
Active
Company

About Ferronova

Ferronova delivers a radiation‑free, nanoparticle‑based lymphatic tracer to enhance precision surgery and imaging for upper GI oncology.

View full company profile

Therapeutic Areas